HEMORRHOIDS RELIEF

Manufacturer: HOMEOLAB USA INC.
Effective date: 2013-11-05
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 01:36:18

Label at a glance#

ProductHEMORRHOIDS RELIEF

Active ingredientHORSE CHESTNUT, WITCH HAZEL, PAEONIA OFFICINALIS ROOT, COLLINSONIA CANADENSIS ROOT, TEUCRIUM MARUM, VERBASCUM THAPSUS, PEUMUS BOLDUS LEAF, SULFUR, SODIUM NITRATE, KRAMERIA LAPPACEA ROOT, NITRIC ACID, SODIUM CHLORIDE, PODOPHYLLUM PELTATUM ROOT, RUTA GRAVEOLENS FLOWERING TOP, APIS MELLIFERA

Label structure10 sections

Indications and uses

This Homeopathic product of natural source helps relieve the discomfort and pain caused by hemorrhoids and fissures.

Dosage and administration

Adults: Allow 3 pellets to dissolve under the tongue 3 times a day, or as directed by a health professional. For adult use only. Do not exceed recommended dosage.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS HPUS

OTC - ACTIVE INGREDIENT SECTION

Aesculus hippocastanum 1X

Hamamelis virginiana 1X

Paeonia officinalis 3X

Collinsonia 3X

Teucrium marum 3X

Verbascum thapsus 3X

Boldo 1X

Sulphur 4X

Sodium nitrate 3X

Ratanhia 3X

Acidum nitricum 8X

Natrum muriaticum 8X

Podophyllum peltatum 4X

Ruta graveolens 8X

Apis mellifica 4X

INACTIVE INGREDIENT SECTION

REFERENCES SECTION

Manufactured according to the Homeopathic Pharmacopoeia of the United States (HPUS)

PURPOSE

OTC - PURPOSE SECTION

Helps relieve discomfort of hemorrhoids and fissures

USES

INDICATIONS & USAGE SECTION

This Homeopathic product of natural source helps relieve the discomfort and pain caused by hemorrhoids and fissures.

OTC - ASK DOCTOR SECTION

If symptoms persist or worsen, discontinue use and contact a health professional.

OTC - PREGNANCY OR BREAST FEEDING SECTION

As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medications out of reach of children.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults: Allow 3 pellets to dissolve under the tongue 3 times a day, or as directed by a health professional.

For adult use only. Do not exceed recommended dosage.

OTHER INFORMATION

OTHER SAFETY INFORMATION

Do not use if cap seal is broken.

Homeolab USA Inc., 3025 De L'Assomption Blvd., Montreal, QC H1N 2H2 Canada

PRODUCT OF CANADA

CARTON

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

IMAGE OF CARTONIMAGE OF LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
60512-9059-1	2025-12-29	C162847	48780-1	9d75b9d0-4fa5-f424-e053-dadaa90a57ce	DRUG FACTS
60512-9059-1	2020-01-31	C162847	48780-1	9d75b9d0-4fa5-f424-e053-dadaa90a57ce	DRUG FACTS

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60512-9059	HEMORRHOIDS RELIEF (AESCULUS HIPPOCASTANUM, HAMAMELIS VIRGINIANA, PAEONIA OFFICINALIS, COLLINSONIA, TEUCRIUM MARUM, VERBASCUM, BOLDO, SULPHUR, SODIUM NITRATE, RATANHIA, ACIDUM NITRICUM, NATRUM MURIATICUM, PODOPHYLLUM PELTATUM, RUTA GRAVEOLENS, APIS MELLIFICA) PELLET [HOMEOLAB USA INC.]	2	Legacy NDC	20140513_0025ae07-e4cb-4ab6-9717-2d172bc24b63.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
APIS MELLIFERA	ACTIVE INGREDIENT	7S82P3R43Z	2
COLLINSONIA CANADENSIS ROOT	ACTIVE INGREDIENT	O2630F3XDR	2
HORSE CHESTNUT	ACTIVE INGREDIENT	3C18L6RJAZ	2
KRAMERIA LAPPACEA ROOT	ACTIVE INGREDIENT	P29ZH1A35Z	2
NITRIC ACID	ACTIVE INGREDIENT	411VRN1TV4	2
PAEONIA OFFICINALIS ROOT	ACTIVE INGREDIENT	8R564U2E1P	2
PEUMUS BOLDUS LEAF	ACTIVE INGREDIENT	Q4EWM09M3O	2
PODOPHYLLUM PELTATUM ROOT	ACTIVE INGREDIENT	2S713A4VP3	2
RUTA GRAVEOLENS FLOWERING TOP	ACTIVE INGREDIENT	N94C2U587S	2
SODIUM CHLORIDE	ACTIVE INGREDIENT	451W47IQ8X	2
SODIUM NITRATE	ACTIVE INGREDIENT	8M4L3H2ZVZ	2
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	2
TEUCRIUM MARUM	ACTIVE INGREDIENT	10464S0TAA	2
VERBASCUM THAPSUS	ACTIVE INGREDIENT	C9TD27U172	2
WITCH HAZEL	ACTIVE INGREDIENT	101I4J0U34	2
APIS MELLIFERA	ACTIVE MOIETY	7S82P3R43Z	2
CHLORIDE ION	ACTIVE MOIETY	Q32ZN48698	2
COLLINSONIA CANADENSIS ROOT	ACTIVE MOIETY	O2630F3XDR	2
HORSE CHESTNUT	ACTIVE MOIETY	3C18L6RJAZ	2
KRAMERIA LAPPACEA ROOT	ACTIVE MOIETY	P29ZH1A35Z	2
NITRATE ION	ACTIVE MOIETY	T93E9Y2844	2
NITRIC ACID	ACTIVE MOIETY	411VRN1TV4	2
PAEONIA OFFICINALIS ROOT	ACTIVE MOIETY	8R564U2E1P	2
PEUMUS BOLDUS LEAF	ACTIVE MOIETY	Q4EWM09M3O	2
PODOPHYLLUM	ACTIVE MOIETY	2S713A4VP3	2
RUTA GRAVEOLENS FLOWERING TOP	ACTIVE MOIETY	N94C2U587S	2
SULFUR	ACTIVE MOIETY	70FD1KFU70	2
TEUCRIUM MARUM	ACTIVE MOIETY	10464S0TAA	2
VERBASCUM THAPSUS	ACTIVE MOIETY	C9TD27U172	2
WITCH HAZEL	ACTIVE MOIETY	101I4J0U34	2
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 22 matching rows.

HEMORRHOIDS RELIEF
AESCULUS HIPPOCASTANUM, HAMAMELIS VIRGINIANA, PAEONIA OFFICINALIS, COLLINSONIA, TEUCRIUM MARUM, VERBASCUM, BOLDO, SULPHUR, SODIUM NITRATE, RATANHIA, ACIDUM NITRICUM, NATRUM MURIATICUM, PODOPHYLLUM PELTATUM, RUTA GRAVEOLENS, APIS MELLIFICA
HORSE CHESTNUT
WITCH HAZEL
PAEONIA OFFICINALIS ROOT
COLLINSONIA CANADENSIS ROOT
TEUCRIUM MARUM
VERBASCUM THAPSUS
PEUMUS BOLDUS LEAF
SULFUR
SODIUM NITRATE
NITRATE ION
KRAMERIA LAPPACEA ROOT
NITRIC ACID
SODIUM CHLORIDE
CHLORIDE ION
PODOPHYLLUM PELTATUM ROOT
PODOPHYLLUM
RUTA GRAVEOLENS FLOWERING TOP
APIS MELLIFERA
SUCROSE
LACTOSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
60512-9059	60512-9059-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
HORSE CHESTNUT	3C18L6RJAZ	ACTIB
WITCH HAZEL	101I4J0U34	ACTIB
PAEONIA OFFICINALIS ROOT	8R564U2E1P	ACTIB
COLLINSONIA CANADENSIS ROOT	O2630F3XDR	ACTIB
TEUCRIUM MARUM	10464S0TAA	ACTIB
VERBASCUM THAPSUS	C9TD27U172	ACTIB
PEUMUS BOLDUS LEAF	Q4EWM09M3O	ACTIB
SULFUR	70FD1KFU70	ACTIB
SODIUM NITRATE	8M4L3H2ZVZ	ACTIB
KRAMERIA LAPPACEA ROOT	P29ZH1A35Z	ACTIB
NITRIC ACID	411VRN1TV4	ACTIB
SODIUM CHLORIDE	451W47IQ8X	ACTIB
PODOPHYLLUM PELTATUM ROOT	2S713A4VP3	ACTIB
RUTA GRAVEOLENS FLOWERING TOP	N94C2U587S	ACTIB
APIS MELLIFERA	7S82P3R43Z	ACTIB
SUCROSE	C151H8M554	IACT
LACTOSE	J2B2A4N98G	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 84 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / SUBLINGUAL	109 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	9.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / BUCCAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION / INTRAVENOUS		1950 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS		308 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LOZENGE / TRANSMUCOSAL		1255 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
4721fb64-bc1c-b450-e063-6294a90a056e			0025ae07-e4cb-4ab6-9717-2d172bc24b63	2025-12-29	Warnings	Exact identifier spl set id: 0025ae07-e4cb-4ab6-9717-2d172bc24b63

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.